Literature DB >> 23943576

'Double midbrain' sign in extensive optic pathway glioma in neurofibromatosis-1.

Puneet Jain1, Rachna Sehgal, Lakshminarayanan Kannan, Atin Kumar, Sheffali Gulati.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23943576     DOI： 10.1007/s12098-013-1186-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  6 in total

1.  Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis.

Authors:  L Kornreich; S Blaser; M Schwarz; A Shuper; T H Vishne; I J Cohen; R Faingold; S Michovitz; B Koplewitz; G Horev
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

Review 2.  Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1.

Authors:  Christin L Sylvester; Lea Ann Drohan; Robert C Sergott
Journal:  Curr Opin Ophthalmol       Date:  2006-02       Impact factor: 3.761

Review 3.  Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

Authors:  Robert Listernick; Rosalie E Ferner; Grant T Liu; David H Gutmann
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

4.  Extensive central nervous system involvement in optic pathway gliomas in neurofibromatosis type 1.

Authors:  Furqan Shaikh; Donna Johnston; Jean Michaud; Julie Hurteau; Michael Vassilyadi; Daniel Keene
Journal:  Pediatr Blood Cancer       Date:  2011-04-04       Impact factor: 3.167

Review 5.  Late-onset optic pathway tumors in children with neurofibromatosis 1.

Authors:  R Listernick; R E Ferner; L Piersall; S Sharif; D H Gutmann; J Charrow
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

6.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

Authors:  R Listernick; J Charrow; M Greenwald; M Mets
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.